Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh

Clinical and Vaccine Immunology

Volumn 20, Issue 10, 2013, Pages 1592-1598

  Rahman, Atiqur ^a,b,c   Rashu, Rasheduzzaman ^b   Bhuiyan, Taufiqur Rahman ^b   Chowdhury, Fahima ^b   Khan, Ashraful Islam ^b   Islam, Kamrul ^b   LaRocque, Regina C ^a,d   Ryan, Edward T ^a,d,e   Wrammert, Jens ^f   Calderwood, Stephen B ^a,d   Qadri, Firdausi ^b   Harris, Jason B ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c UNIVERSITY OF DHAKA   (Bangladesh)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD19 ANTIGEN; CD20 ANTIGEN; CD27 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY RESPONSE; ANTIBODY SECRETING CELL; ARTICLE; BANGLADESH; BLOOD GROUP ABO SYSTEM; CELL ISOLATION; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSPOT ASSAY; FECES ANALYSIS; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MALE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; SECRETORY CELL; VIBRIO CHOLERAE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIBODY-PRODUCING CELLS; BANGLADESH; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; COHORT STUDIES; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; LIPOPOLYSACCHARIDES; MALE; VIBRIO CHOLERAE O1; YOUNG ADULT;

EID: 84886741982     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00347-13     Document Type: Article

References (24)

1. World Health Organization. 2010. Cholera vaccines: WHO position paper. Wkly. Epidemiol. Rec. 85:117-128.
2. Harris JB, Larocque RC, Charles RC, Mazumder RN, Khan AI, Bardhan PK. 2010. Cholera's western front. Lancet 376:1961-1965.
3. Ryan ET. 2011. The cholera pandemic, still with us after half a century: time to rethink. PLoS Negl. Trop. Dis. 5:e1003. doi:10.1371/journal.pntd. 0001003.
4. Clemens JD, Sack DA, Harris JR, Van Loon F, Chakraborty J, Ahmed F, Rao MR, Khan MR, Yunus M, Huda N, Stanton BF, Kay E, Eeckels R, Walter S, Svennerholm AM, Holmgren J. 2009. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335:270-273.
5. Deen JL, von Seidlein L, Sur D, Agtini M, Lucas MES, Lopez AL, Kim DR, Ali M, Clemens JD. 2008. The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl. Trop. Dis. 2:e173. doi:10.1371/journal.pntd.0000173.
6. Glass RI, Becker S, Huq MI, Stoll BJ, Khan MU, Merson MH, Lee JV, Black RE. 1982. Endemic cholera in rural Bangladesh, 1966-1980. Am. J. Epidemiol. 116:959-970.
7. Koelle K, Rodó X, Pascual M, Yunus M, Mostafa G. 2005. Refractory periods and climate forcing in cholera dynamics. Nature 436:696-700.
8. Levine MM, Black RE, Clements ML, Cisneros L, Nalin DR, Young CR. 1981. Duration of infection-derived immunity to cholera. J. Infect. Dis. 143:818-820.
9. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD. 2009. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet 374:1694-1702.
10. Alam MM, Riyadh MA, Fatema K, Rahman MA, Akhtar N, Ahmed T, Chowdhury MI, Chowdhury F, Calderwood SB, Harris JB, Ryan ET, Qadri F. 2011. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin. Vaccine Immunol. 18:844-850.
11. Patel SM, Rahman MA, Mohasin M, Riyadh MA, Leung DT, Alam MM, Chowdhury F, Khan AI, Weil AA, Aktar A, Nazim M, LaRocque RC, Ryan ET, Calderwood SB, Qadri F, Harris JB. 2012. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh. Clin. Vaccine Immunol. 19:842-848.
12. Qadri F, Mäkelä PH, Holmgren J, Albert MJ, Mannoor K, Kantele A, Saha D, Salam MA, Kantele JM. 1998. Enteric infections in an endemic area induce a circulating antibody-secreting cell response with homing potentials to both mucosal and systemic tissues. J. Infect. Dis. 177:1594-1599.
13. Uddin T, Harris JB, Bhuiyan TR, Shirin T, Uddin MI, Khan AI, Chowdhury F, LaRocque RC, Alam NH, Ryan ET, Calderwood SB, Qadri F. 2011. Mucosal immunologic responses in cholera patients in Bangladesh. Clin. Vaccine Immunol. 18:506-512.
14. Qadri F, Jonson G, Begum YA, Wennerås C, Albert MJ, Salam MA, Svennerholm AM. 1997. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139. Clin. Diagn. Lab. Immunol. 4:429-434.
15. Qadri F, Ryan ET, Faruque AS, Ahmed F, Khan AI, Islam MM, Akramuzzaman SM, Sack DA, Calderwood SB. 2003. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers. Infect. Immun. 71:4808-4814.
16. Johnson RA, Uddin T, Aktar A, Mohasin M, Alam MM, Chowdhury F, Harris JB, LaRocque RC, Bufano MK, Yu Y, Wu-Freeman Y, Leung DT, Sarracino D, Krastins B, Charles RC, Xu P, Kovác P, Calderwood SB, Qadri F, Ryan ET. 2012. Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera. Clin. Vaccine Immunol. 19:1712-1721.
17. Shamsuzzaman S, Ahmed T, Mannoor K, Begum YA, Bardhan PK, Sack RB, Sack DA, Svennerholm AM, Holmgren J, Qadri F. 2009. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses. Vaccine 27:1386-1392.
18. Jayasekera CR, Harris JB, Bhuiyan S, Chowdhury F, Khan AI, Faruque AS, Larocque RC, Ryan ET, Ahmed R, Qadri F, Calderwood SB. 2008. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J. Infect. Dis. 198:1055-1061.
19. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, McCausland M, Skountzou I, Hornig M, Lipkin WI, Mehta A, Razavi B, Del Rio C, Zheng NY, Lee JH, Huang M, Ali Z, Kaur K, Andrews S, Amara RR, Wang Y, Das SR, O'Donnell CD, Yewdell JW, Subbarao K, Marasco WA, Mulligan MJ, Compans R, Ahmed R, Wilson PC. 2011. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208:181-193.
20. Wrammert J, Onlamoon N, Akondy RS, Perng GC, Polsrila K, Chandele A, Kwissa M, Pulendran B, Wilson PC, Wittawatmongkol O, Yoksan S, Angkasekwinai N, Pattanapanyasat K, Chokephaibulkit K, Ahmed R. 2012. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J. Virol. 86:2911-2918.
21. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, James J, Air GM, Capra JD, Ahmed R, Wilson PC. 2008. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453:667-671.
22. Sasaki S, Sullivan M, Narvaez CF, Holmes TH, Furman D, Zheng NY, Nishtala M, Wrammert J, Smith K, James JA, Dekker CL, Davis MM, Wilson PC, Greenberg HB, He XS. 2011. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J. Clin. Invest. 121:3109-3119.
23. Czerkinsky C, Svennerholm AM, Quiding M, Jonsson R, Holmgren J. 1991. Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. Infect. Immun. 59:996-1001.
24. Qadri F, Wennerås C, Ahmed F, Asaduzzaman M, Saha D, Albert MJ, Sack RB, Svennerholm A. 2000. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children. Vaccine 18:2704-2712.